STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZURA
  4. [Form 4] Zura Bio Ltd Insider Trading Activity

Zura Bio (ZURA) director awarded 51,000 share options at $3.62

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zura Bio Ltd director Parvinder Thiara received a grant of share options covering 51,000 Class A Ordinary Shares. The options have an exercise price of $3.62 and expire on June 17, 2036. They vest in twelve roughly equal monthly installments starting June 17, 2026, with any remaining unvested portion vesting just before the next annual shareholder meeting, subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Thiara Parvinder
Role null
Type Security Shares Price Value
Grant/Award Share Option (Right to Buy) 51,000 $0.00 --
Holdings After Transaction: Share Option (Right to Buy) — 51,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 51,000 options Share Option (Right to Buy) covering Class A Ordinary Shares
Exercise price $3.62 per share Conversion or exercise price for granted options
Expiration date June 17, 2036 Option expiration for 51,000-share grant
Total options after grant 51,000 options Total derivative securities following transaction
Vesting schedule 12 monthly installments over one year Measured from June 17, 2026, subject to continued service
Share Option (Right to Buy) financial
"security_title: "Share Option (Right to Buy)""
Class A Ordinary Shares financial
"underlying_security_title: "Class A Ordinary Shares""
Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.
exercise price financial
"conversion_or_exercise_price: "3.6200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"This option vests in twelve substantially equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-17T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thiara Parvinder
(Last)(First)(Middle)
C/O ZURA BIO LTD
1489 W. WARM SPRINGS RD. #110
(Street)
HENDERSON NEVADA 89014
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Zura Bio Ltd [ ZURA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Share Option (Right to Buy)$3.6206/17/2026A51,000 (1)06/17/2036Class A Ordinary Shares51,000$051,000D
Explanation of Responses:
1. This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date.
/s/ Kim Davis, Attorney-in-Fact06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Zura Bio (ZURA) director Parvinder Thiara report on this Form 4?

Parvinder Thiara reported receiving a grant of options for 51,000 Class A Ordinary Shares. These share options give the right to buy Zura Bio stock at a set price, reflecting routine equity-based director compensation rather than an open-market trade.

How many Zura Bio shares are covered by the new options granted to Parvinder Thiara?

The grant covers options on 51,000 Class A Ordinary Shares of Zura Bio. This figure also matches the total derivative securities held following the transaction, indicating this award establishes Thiara’s reported option position in this filing.

What is the exercise price of Parvinder Thiara’s Zura Bio stock options?

The options carry an exercise price of $3.62 per share. This means Thiara can purchase each underlying Class A Ordinary Share at $3.62 once the options vest, regardless of Zura Bio’s future market price at exercise.

When do Parvinder Thiara’s Zura Bio options begin vesting and over what period?

The options begin vesting from June 17, 2026, in twelve substantially equal monthly installments over one year. Vesting requires Thiara’s continued service, so each monthly portion becomes exercisable only if service conditions are satisfied at that date.

When do the Zura Bio stock options granted to Parvinder Thiara expire?

The options expire on June 17, 2036. After this expiration date, any unexercised portion of the 51,000-share award can no longer be used to purchase Class A Ordinary Shares at the $3.62 exercise price.

Is there any accelerated vesting feature in Parvinder Thiara’s Zura Bio option grant?

Yes. Any remaining unvested portion of the option grant will fully vest on the day immediately before the next annual shareholder meeting following the grant date, provided Thiara continues to serve through each applicable vesting date.